September Buy, Sell or Hold for This Pharma Sock: Catalyst Pharmaceuticals (CPRX)
Catalyst Pharmaceuticals (CPRX) delivered a robust performance in its last reported quarter. So, is now the right entry point in the stock? Let’s look at its financial metrics to gauge its prospects.
StockNews.com ·